References

1. Rutkow IM, Ernst CB (1986) An analysis of vascular surgical manpower requirements and vascular surgical rates in the United States. J Vasc Surg 3:74-83

2. Management of peripheral arterial disease (PAD) (2000) TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg 31, part 2 (Supplement):S5

3. Hessel SJ, Adams DF, Abrams HL (1981) Complications of angiography. Radiology 138:273-281

4. AbuRahma AF, Robinson PA, Boland JP et al (1993) Complications of arteriography in a recent series of 707 cases: factors affecting outcome. Ann Vasc Surg 7:122-129

5. Shehadi WH (1982) Contrast media adverse reactions: occurrence, recurrence, and distribution patterns. Radiology 143:11-17

6. Shellock FG, Kanal E (1999) Safety of magnetic resonance imaging contrast agents. J Magn Reson Imaging 10:477-84

7. Prince MR (1994) Gadolinium-enhanced MR aortography. Radiology 191:155-164

8. Prince MR, Narasimham DL, Stanley JC et al (1995) Breath-hold gadolinium-enhanced Mr angiography of the abdominal aorta and its major branches. Radiology 197:785-792

9. Meaney JF, Weg JG, Chenevert TL et al (1997) Diagnosis of pulmonary embolism with magnetic resonance angiography. N Engl J Med 336: 1422-1427

10. Goyen M, Debatin JF, Ruehm SG (2001) Peripheral MR-Angiography Top Magn Res Imaging 12:327335

11. Meaney JF, Ridgway JP, Chakraverty S et al (1999) Stepping-table gadolinium-enhanced digital subtraction MR angiography of the aorta and lower extremity arteries: preliminary experience. Radiology 211:59-67

12. Ho KY, Leiner T, de Haan MW et al (1998) Peripheral vascular tree stenoses: evaluation with moving-bed infusion-tracking MR angiography. Radiology 206:683-692

13. Ruehm SG, Hany TF, Pfammatter T et al (2000) Pelvic and lower extremity arterial imaging: diagnostic performance of three-dimensional contrast-enhanced MR angiography. Am J Roentgenol 174:1127-1135

14. Goyen M, Ruehm SG, Barkhausen J et al (2001) Improved Multi-Station Peripheral MR Angiography with a Dedicated Vascular Coil J Magn Reson Imaging 13:475-480

15. Ruehm SG, Goyen M, Barkhausen J et al (2001) Rapid magnetic resonance angiography for detection of atherosclerosis. Lancet 357:1086-1091

16. Ruehm SG, Goyen M, Quick HH et al (2000) Whole-body MRA on a rolling table platform (AngioSURF) RöFo 172:670-674

17. Goyen M, Herborn CU, Lauenstein TC et al (2002) High-Resolution Whole-Body 3D MR-Angiography using AngioSURF: Assessment of Optimal Contrast Dosage Invest Radiol 37:263-268

18. Goyen M, Quick HH, Debatin JF et al (2002) High Resolution Whole Body 3D MR Angiography (An-gioSURF): Initial Clinical Experience Radiology

19. Cavagna FM, Maggioni F, Castelli PM et al (1997) Gadolinium chelates with weak binding to serum proteins. A new class of high-efficiency, general purpose contrast agents for magnetic resonance imaging. Invest Radiol 32:780-796

20. Management of peripheral arterial disease (PAD) (2000) TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg 31, part 2 (Supplement):S69

21. Goyen M, Herborn CU, Kröger K et al (2003) Detection of atherosclerosis: systemic imaging for systemic disease with whole-body three-dimensional MR angiography - initial experience. Radiology 227:277-282.

22. Von Kemp K, van den Brande P, Peterson T et al (1997) Screening for concomitant diseases in peripheral vascular patients. Results of a systematic approach. Int Angiol 16:114-122

23. Klop RB, Eikelboom BC, Taks AC et al (1991) Screening of the internal carotid arteries in patients with peripheral vascular disease by colour-flow duplex scanning. Eur J Vasc Surg 5:41-45

24. Alexandrova NA, Gibson WC, Norris JW et al (1996) Carotid artery stenosis in peripheral vascular disease. J Vasc Surg 23:645-649

25. McDaniel MD, Cronenwett JL (1989) Basic data related to the natural history of intermittent claudication. Ann Vasc Surg 3:273-277

26. Marek J, Mills JL, Harvich J et al (1996) Utility of routine carotid duplex screening in patients who have claudication. J Vasc Surg 24:572-577 discussion 577-9

27. Kreitner KF, Kalden P, Neufang A et al (2000) Diabetes and peripheral arterial occlusive disease: prospective comparison of contrast-enhanced three-dimensional MR angiography with conventional digital subtraction angiography. AJR Am J Roentgenol 174:171-179

28. Herborn CU, Ajaj W, Goyen M et al (2004) Peripheral vasculature: whole-body MR angiography with midfemoral venous compression—initial experience. Radiology. 230: 872-878

29. Maki JH, Wilson GJ, Eubank WB et al (2002) Utilizing SENSE to achieve lower station sub-millimeter isotropic resolution and minimal venous enhancement in peripheral MR angiography. J Magn Reson Imaging 15:484-491

30. Swan JS, Carroll TJ, Kennell TW et al (2002) Time-resolved three-dimensional contrast-enhanced MR angiography of the peripheral vessels. Radiology 225:43-52

31. Korosec FR, Frayne R, Grist TM (1996) Time-resolved contrast-enhanced 3D MR angiography. Magn Reson Med 36:345-351

32. Ruehm SG, Zimny K, Debatin JF (2001) Direct contrast-enhanced 3D MR venography. Eur Radiol 11:102-112

33. Bilecen D, Aschwanden M, Heidecker HG et al (2004) Optimized assessment of hand vasculariza-tion on contrast-enhanced MR angiography with a subsystolic continuous compression technique. AJR Am J Roentgenol 182:180-182

34. Goyen M, Ruehm SG, Debatin JF (2000) MR-An-giography: The Role of Contrast Agents European Journal of Radiology 34: 247-56

35. Knopp MV, von Tengg-Kobligk H, Floemer F et al (1999) Contrast agents for MRA: future directions. J Magn Reson Imaging 10:314-316

36. Goyen M, Lauenstein TC, Herborn CU et al (2001) 0.5 M Gd-Chelate (Magnevist) vs. 1.0 M Gd-Chelate (Gadovist): Dose-independent Effect on Image Quality of Pelvic 3D MRA J Magn Reson Imaging 14:602-607

Was this article helpful?

0 0
Your Heart and Nutrition

Your Heart and Nutrition

Prevention is better than a cure. Learn how to cherish your heart by taking the necessary means to keep it pumping healthily and steadily through your life.

Get My Free Ebook


Post a comment